159 related articles for article (PubMed ID: 34290022)
1. Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma.
Hata K; Sakaguchi C; Tsuchiya M; Nagasaka Y
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290022
[TBL] [Abstract][Full Text] [Related]
2. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
3. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Isolated ACTH Deficiency Induced by Nivolumab in a Patient with Gastric Cancer Metastasis of the Peritoneum].
Mashita N; Otake K; Nonogaki A; Saito H; Nakamura M; Yamanaka M; Tobinaga J; Ishigure K
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1879-1882. PubMed ID: 31879407
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
[TBL] [Abstract][Full Text] [Related]
6. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
[TBL] [Abstract][Full Text] [Related]
7. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
Iglesias P; Sánchez JC; Díez JJ
Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
[TBL] [Abstract][Full Text] [Related]
8. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
[TBL] [Abstract][Full Text] [Related]
9. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Hanazaki K
Clin J Gastroenterol; 2021 Aug; 14(4):988-993. PubMed ID: 33715100
[TBL] [Abstract][Full Text] [Related]
10. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
[TBL] [Abstract][Full Text] [Related]
11. Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer.
Hihara K; Sato H; Okamoto I; Katsube Y; Maruyama R; Tomioka R; Tanaka H; Tsukahara K
Auris Nasus Larynx; 2019 Dec; 46(6):896-901. PubMed ID: 31350019
[TBL] [Abstract][Full Text] [Related]
12. Adrenal insufficiency following nivolumab therapy in patients with recurrent or metastatic head and neck cancer.
Kagoshima H; Hori R; Kojima T; Okanoue Y; Fujimura S; Taguchi A; Shoji K
Auris Nasus Larynx; 2020 Apr; 47(2):309-313. PubMed ID: 31235078
[TBL] [Abstract][Full Text] [Related]
13. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
Pierrard J; Petit B; Lejeune S; Seront E
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439558
[TBL] [Abstract][Full Text] [Related]
14. Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer.
Takaya K; Sonoda M; Fuchigami A; Hiyoshi T
Intern Med; 2017 Sep; 56(18):2463-2469. PubMed ID: 28824067
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
16. Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell Carcinoma.
Seki T; Yasuda A; Oki M; Kitajima N; Takagi A; Nakajima N; Miyajima A; Fukagawa M
Tokai J Exp Clin Med; 2017 Sep; 42(3):115-120. PubMed ID: 28871578
[TBL] [Abstract][Full Text] [Related]
17. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
[TBL] [Abstract][Full Text] [Related]
18. Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy.
Narahira A; Yanagi T; Cho KY; Nakamura A; Miyoshi H; Hata H; Imafuku K; Kitamura S; Shimizu H
J Dermatol; 2017 Apr; 44(4):e70. PubMed ID: 27608187
[No Abstract] [Full Text] [Related]
19. A middle aged woman with isolated ACTH deficiency associated with transient growth hormone deficiency.
Hernán Martínez J; Mangual Garcia MM; Gutiérrez Acevedo M; Sánchez Cruz A; Laboy I; Rivera C; Mansilla P; Palermo Garofalo C; Lourdes Miranda M; Torres Rafael O
Bol Asoc Med P R; 2016; 108(1):5-8. PubMed ID: 29192748
[TBL] [Abstract][Full Text] [Related]
20. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.
Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T
Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]